Drupal.behaviors.print = function(context) {window.print();window.close();}>
Array Orders Surge for Illumina in Q4, But Revenues Slip Due to Manufacturing Constraints
February 14, 2012
Array Orders Surge for Illumina in Q4, But Revenues Slip Due to Manufacturing Constraints
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Roche Won't Extend Offer for Illumina as Shareholders Re-elect Flatley, Others to Board
April 18, 2012 / GenomeWeb Daily News
Analyst: Illumina Shareholders Unlikely to Vote for Roche Offer, but Options Remain
April 17, 2012 / GenomeWeb Daily News
Third Proxy Firm Favors Re-election of Illumina Board Members over Roche Candidates
April 10, 2012 / GenomeWeb Daily News
ISS Recommends Illumina Shareholders Vote Against Roche's Nominees for Board
April 6, 2012 / GenomeWeb Daily News
In Second Letter, Roche Urges Illumina Shareholders to Accept 'Highly Attractive' Offer
April 4, 2012 / GenomeWeb Daily News